V. M. Polonskii
|
|
V.F. Semiglazov, G.A. Dashian, V.V. Semiglazov, R.M. Paltuev, N.Sh. Migmanova, O.A. Ivanova, T.T. Tabagua
Treatment Of “triple-negative” Breast Cancer
|
14-17 |
G.A. Dashian, V.F. Semiglazov, V.V. Semiglazov, N.Sh. Migmanova, O.A. T.T. Tabagua, A.G. Vasilyev
Breast Cancer And Pregnancy
|
18-22 |
N.B. Mihailova
Rituximab In The Treatment Of Chronic Lymphocytic Leukemia: Abstract Review
|
23-26 |
A.N. Lud, I.P. Ganshina
Bevacizumab (avastin) In The Treatment Of Patients With Breast Cancer
|
27-30 |
S.L. Gutorov, E.I. Borisova, M.R. Lichinicer
Sunitinib (sutent) In The First Line Of Metastatic Renal Cell Carcinoma
|
31-34 |
V.F. Semiglazov, G.A. Dashian, V.V. Semiglazov, R.V. Dovskih, R.M. Paltuev
Treatment Of Operable And Relatively Operable Forms Of Breast Cancer
|
35-40 |
A.V. Smolin, G.L. Kobyakov, A.V. Konev, S.N. Nikolaeva, Yu.E. Shamanskaya, T.G. Solovei
Possibilities Of Antiangiogenic Therapy In Recurrent High-grade Malignant Gliomas
|
41-48 |
L.V. Bolotina
Current Options Of Gastrointestinal Stromal Tumors Therapy: Clinical Observation
|
49-52 |
A.N. Lud
Capecitabine In The Treatment Of Patients With Gastric Cancer
|
53-56 |
I.S. Bazin
Use Of The Drug Nexavar (sorafenib) For The Treatment Of Hepatocellular Cancer
|
57-61 |
A.K. Vertkin, A.I. Kodjushkov, O.V. Kozlova
First Revealed Gynecological Cancer As The Cause Of Death In Multifield Hospital
|
62-65 |
I.S. Krysanov
Bone Metastasis Of Breast Cancer: How Much Does Bisphosphonate Therapy Cost?
|
66-68 |
L.G. Fechina, O.P. Hlebnikova, N.Yu. Shipovskaya, A.G. beznoschenko, O.B. Polushkina, O.V. Aleinikova, V.V. Lebedev, A.F. Karelin, E.V. Inushkina, L.P. Privalova, N.A. Popova, R.A. Ivanov, Yu.F. She, A.A. Maschan
Results Of Multicenter Comparative Study Of Safety And Efficacy Of The Drugs Leucostim? And Neupogen? In The Treatment And Prophylaxis Of Neutropenia In Children
|
69-76 |
A.L. Vertkin, A.V. Naumov, M.M. Shamuilova, P.A. Semenov, M.K. Tamkaeva, V.S. Ivanov
Efficacy And Safety Of Lornoxicam Use For The Rapid Relief Of Pain Syndromes In Patients With Oncological Diseases In General Somatic Practice
|
78-82 |
A.L. Vertkin, A.V. Naumov, O.V. Kozlova, E.V. Maximenko, Yu. A. Himich
Prevalence, Peculiarities Of The Course And Pharmacotherapy Of Osteoporosis In Oncological Patients
|
83-87 |